Can thymosin alpha 1 cause cancer?
This site's thymosin alpha-1 studies do not measure cancer. The largest is the TESTS sepsis study (1,106 adults; 23.4% died within 28 days, versus 24.1% on a dummy treatment). A 98-person hepatitis B study found the virus was fully cleared at 18 months in 40.6% after a 26-week course, versus 9.4% of people who were not treated. Cancer support care is listed as a research area, which is not a counted finding that it causes cancer. This FAQ does not invent a cancer rate from silence.
Studies in people from the compound pages this answer belongs to
- Thymosin Alpha-1
- Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial 1998 PMID 9581695
- The efficacy and safety of thymosin alpha 1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial 2025 PMID 39814420
- The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial 2013 PMID 23327199
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of further names and published absences. Leftover harvested questions after the first two absence sets: more brand versus molecule names, side effects the citations did not count, compounding formulas this catalogue does not hold, national FDA and Australia fields, trial windows rather than an onset clock, named combinations with no interaction table, and oral routes that have not been studied.